Interestingly, previous studies investigating the role of LSD1 in ovarian cancer consistently showed that LSD1 was overexpressed in ovarian cancer and that LSD1 overexpression was associated with poor survival of ovarian cancer patients [31,32]. Here, KDM1A is linked to ovarian cancer.